期刊文献+

非小细胞肺癌放疗抵抗细胞模型的建立与鉴定 被引量:5

Establishment and identification of radioresistant non-small cell lung cancer model
下载PDF
导出
摘要 目的体外建立非小细胞肺癌A549放疗抵抗模型,为进一步研究放疗抵抗的机制和治疗提供实验基础。方法摸索接种细胞数量及诱导照射剂量;采用间歇照射诱导建立放疗抵抗细胞模型RA549;倒置显微镜观察细胞形态;克隆形成实验鉴定RA549的放疗抵抗性。结果照射后RA549细胞形态较亲本A549细胞变长、变大,但传代5代后又可恢复;RA549细胞的存活分数明显大于亲本细胞。结论间歇照射诱导可以成功建立稳定的、具有放疗抵抗性的肺癌细胞模型。 Objective To establish a radioresistant model of non-small-cell cancer A549,and to provide the experimental basis for further researchonradioresistance. Methods The cell number and the dose of radiation therapy were confirmed. The intermittent radiation were used to induce the radioresistant cell model. The morphology of cells were observed with an inverted phase contrast microscope. Colony formation was used to identify the radioresistance of the RA549 cell.Results RA549 cells were longer and bigger than A549 cells; surviving fraction of RA549 was significantly increased than A549. Conclusion Intermittent radiation can successfully induce the radioresistant cell model of lung cancer cells.
出处 《解剖学报》 CAS CSCD 北大核心 2017年第2期156-159,共4页 Acta Anatomica Sinica
基金 河北省高等学校科学技术研究项目(QN2014036) 河北省卫生厅重点课题(ZL20140247) 承德市科学技术研究项目(20142015) 2016年国家级大学生创新创业训练计划项目(201609)
关键词 非小细胞肺癌 放疗抵抗 克隆形成 组织化学 Non-small-cell cancer Radioresistance Colony formation Histochemistry
  • 相关文献

参考文献3

二级参考文献17

  • 1任建华,李瑞明,李超,熊奎,骆志国.放射抗拒食管癌细胞系的建立及抗拒机制研究[J].中国肿瘤,2009,18(11):912-915. 被引量:3
  • 2夏云飞,胡永红,张恩罴.放射生物学线性二次模型的哲学思考[J].医学与哲学,1996,17(2):98-99. 被引量:1
  • 3林金清,肖春妹,谭平华,金春英.应用Origin软件估算非线性方程的模型参数[J].计算机与应用化学,2006,23(3):271-274. 被引量:15
  • 4[2]Sculier JP,Paesmans M,Libert P,et al.Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer.European Lung Cancer Working Party.Eur J Cancer,1994,30A(9):1342-1347.
  • 5[3]Natale RB.Overview of current and future chemotherapeutic agents in non-small cell lung cancer.Semin Oncol,1997,24 (2 Suppl 7):S7-29-S7-37.
  • 6[4]Non-small Cell Lung Cancer Collaborative Group.Chemotherapy in non-small cell lung cancer:a meta-analysis using updated data on individual patients from 52 randomised clinical trials.BMJ,1995,311(7010):899-909.
  • 7[5]Kubota K,Nishiwaki Y,Ohashi Y,et al.The four-arm cooperative study (FACS) for advanced non-small-cell lung cancer (NSCLC).J Clin Oncol,Proc Annu Meet Am Soc Clin Oncol,2004,22(14S):7006.
  • 8[6]Kelly K,Crowley J,Bunn PA Jr,et al.Randomized phase Ⅲ trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer:a Southwest Oncology Group trial.J Clin Oncol,2001,19(13):32103218.
  • 9[7]Waechter F,Passweg J,Tamm M,et al.Significant progress in palliative treatment of non-small cell lung cancer in the past decade.Chest,2005,127(3):738-747.
  • 10[8]Schiller JH,Harrington D,Belani CP,et al; Eastern Cooperative Oncology Group.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.N Engl J Med,2002,346 (2):92-98.

共引文献11

同被引文献28

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部